NCT05620355 2023-03-21
Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.
Bio Genuine (Shanghai) Biotech Co., Ltd.
Phase 3 Unknown
Bio Genuine (Shanghai) Biotech Co., Ltd.
Legacy Health System
Mirabilis Medica, Inc.
Oslo University Hospital
Ullevaal University Hospital